Skip to content
Home/Companies/Biotech/Crucible Therapeutics
CT

Crucible Therapeutics

Biotech·UK·Active·3yr hold

Crucible Therapeutics is a biotech company, headquartered in UK.

Entry
2023
Hold
3yr
Status
Active
Est. EV
–

Who owns Crucible Therapeutics?

Crucible Therapeutics is currently owned by Northern Gritstone through Northern Gritstone Evergreen (2020 vintage), since 2023.

Hand-verified · updated 2026-06-02

Northern Gritstone
Investor
Northern Gritstone
Northern Gritstone Evergreen · 2020 · Evergreen

Key facts

HQUK
SectorBiotech
StatusActive

More from Northern Gritstone Evergreen

Other portfolio companies in the same fund.

AmpliSi
Active
Deep TechUK· 2026
Cytotrait
Active
AgTechUK· 2026
Apini Therapeutics
Active
BiotechUK· 2025
IVFmicro
Active
MedTechUK· 2025
Literal Labs
Active
AI/MLUK· 2025
OLO Robotics
Active
Deep TechUK· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings